Clinical trial
2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in…
NCT00223977 · Watson Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00223977 |
|---|---|
| Title | 2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients. |
| Official title | A Multi-center, Randomized, Open Label Study of the Efficacy and Safety of Two Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peroneal Dialysis Patients Receiving Erythropoietin. |
| Lead sponsor | Watson Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Iron Deficiency Anemia |
| Intervention type | Drug |
| Interventions | Sodium Ferric Gluconate Complex, Oral Iron |
| Enrollment | 146 |
| Start date | Dec 1, 2003 |
| Primary completion | Nov 1, 2004 |
| Completion | Feb 1, 2008 |
| First posted | Sep 22, 2005 |
| Last update posted | Jul 8, 2013 |
| Countries | Bulgaria, Canada, Croatia, India, Mexico, Poland, Russia, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: